1. Home
  2. XOMA vs RFI Comparison

XOMA vs RFI Comparison

Compare XOMA & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • RFI
  • Stock Information
  • Founded
  • XOMA 1981
  • RFI 1992
  • Country
  • XOMA United States
  • RFI United States
  • Employees
  • XOMA N/A
  • RFI N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • RFI Investment Managers
  • Sector
  • XOMA Health Care
  • RFI Finance
  • Exchange
  • XOMA Nasdaq
  • RFI Nasdaq
  • Market Cap
  • XOMA 355.6M
  • RFI 349.2M
  • IPO Year
  • XOMA N/A
  • RFI N/A
  • Fundamental
  • Price
  • XOMA $30.21
  • RFI $12.38
  • Analyst Decision
  • XOMA Strong Buy
  • RFI
  • Analyst Count
  • XOMA 2
  • RFI 0
  • Target Price
  • XOMA $78.50
  • RFI N/A
  • AVG Volume (30 Days)
  • XOMA 30.4K
  • RFI 69.8K
  • Earning Date
  • XOMA 11-07-2024
  • RFI 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • RFI 8.25%
  • EPS Growth
  • XOMA N/A
  • RFI N/A
  • EPS
  • XOMA N/A
  • RFI N/A
  • Revenue
  • XOMA $21,606,000.00
  • RFI N/A
  • Revenue This Year
  • XOMA $488.61
  • RFI N/A
  • Revenue Next Year
  • XOMA $27.42
  • RFI N/A
  • P/E Ratio
  • XOMA N/A
  • RFI N/A
  • Revenue Growth
  • XOMA 389.82
  • RFI N/A
  • 52 Week Low
  • XOMA $14.33
  • RFI $9.62
  • 52 Week High
  • XOMA $33.78
  • RFI $12.52
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 52.03
  • RFI 37.69
  • Support Level
  • XOMA $29.09
  • RFI $12.51
  • Resistance Level
  • XOMA $32.50
  • RFI $13.24
  • Average True Range (ATR)
  • XOMA 1.87
  • RFI 0.23
  • MACD
  • XOMA -0.17
  • RFI -0.05
  • Stochastic Oscillator
  • XOMA 49.29
  • RFI 5.49

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About RFI Cohen & Steers Total Return Realty Fund Inc.

Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.

Share on Social Networks: